manufacturer

Featured Health & Pharmaceuticals Marketing & Consulting

Actavis generic prostate cancer drug Bicalutamide first to market in UK, Germany, France

July 10, 2008July 27, 20152 min read

Reykjavik, Iceland, 10 July 2008 — Actavis Group, the international generic pharmaceuticals company, today announced the launch of Bicalutamide tablets in the United Kingdom, Germany

Tag: manufacturer

Actavis generic prostate cancer drug Bicalutamide first to market in UK, Germany, France

You May Have Missed

Inzynk takes focus on the UK to Dismantle B2B MarTech’s Per-Seat ‘SaaS Tax’

Xpress Health NI Expands Nursing Opportunities Across Northern Ireland to Meet Surging Healthcare Demand

Growing Manufacturing Workforce Requirements Create Opportunities for International Workers

Site Design Squad Launches Hands-On Web Accessibility Audits for Small Businesses and Charities